Chemoinformaics analysis of GAMMA-L-GLUTAMYL-ISOLEUCINE
| Molecular Weight | 259.282 | nRot | 8 |
| Heavy Atom Molecular Weight | 240.13 | nRig | 3 |
| Exact Molecular Weight | 259.13 | nRing | 0 |
| Solubility: LogS | -1.552 | nHRing | 0 |
| Solubility: LogP | -2.467 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 37.2491 |
| nHD | 2 | BPOL | 22.8309 |
| QED | 0.478 |
| Synth | 2.997 |
| Natural Product Likeliness | 0.386 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.082 |
| HIA | 0.42 |
| CACO-2 | -6.139 |
| MDCK | 0.00381884 |
| BBB | 0.585 |
| PPB | 0.090875 |
| VDSS | 0.371 |
| FU | 0.735215 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.044 |
| CYP2c9-inh | 0.066 |
| CYP2c9-sub | 0.56 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.113 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.012 |
| CL | 4.386 |
| T12 | 0.737 |
| hERG | 0.01 |
| Ames | 0.003 |
| ROA | 0.01 |
| SkinSen | 0.09 |
| Carcinogencity | 0.017 |
| EI | 0.041 |
| Respiratory | 0.054 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.686932 |